Reversible DNA Hypermethylation of the Interleukin-15 (IL-15) Promoter Induces IL-15 Expression, Drives the Pathogenesis of T-Cell Large Granular Lymphocytic Leukemia and Provides a Potential Therapeutic Approach Using 5-Azacitidine. By: Brammer E., Boles A.E., Mansour A., Freud A.G., Mathé-Allainmat M., Quéméner A., Mortier E., Porcu P. and Mishra A. Blood (2019) 134 (Splt. 1): 3776. DOI: https://doi.org/10.1182/blood-2019-131174
BTN2A, a New Immune-Checkpoint Targeting Vg9Vd2 T Cell Cytotoxicity. By: Cano C.E. Pasero C., De Gassart A., Hoet R., Scotet E., Mortier E., Quéméner A., Rafia C., Briantais A., Le Floch A.-C., and Olive D. Blood (2019) 134 (Splt. 1): 1044. DOI: https://doi.org/10.1182/blood-2019-128658